Emmaus Life Sciences Inc (EMMA)
0.105
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Emmaus Life Sciences Max Drawdown (5Y): 99.64% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.64% |
March 31, 2024 | 99.64% |
February 29, 2024 | 99.64% |
January 31, 2024 | 99.64% |
December 31, 2023 | 99.64% |
November 30, 2023 | 99.64% |
October 31, 2023 | 99.64% |
September 30, 2023 | 99.64% |
August 31, 2023 | 99.64% |
July 31, 2023 | 99.64% |
June 30, 2023 | 99.64% |
May 31, 2023 | 99.64% |
April 30, 2023 | 99.64% |
March 31, 2023 | 99.64% |
February 28, 2023 | 99.64% |
January 31, 2023 | 99.64% |
December 31, 2022 | 99.71% |
November 30, 2022 | 99.71% |
October 31, 2022 | 99.71% |
September 30, 2022 | 99.71% |
August 31, 2022 | 99.71% |
July 31, 2022 | 99.71% |
June 30, 2022 | 99.71% |
May 31, 2022 | 99.71% |
April 30, 2022 | 99.71% |
Date | Value |
---|---|
March 31, 2022 | 99.71% |
February 28, 2022 | 99.71% |
January 31, 2022 | 99.71% |
December 31, 2021 | 99.71% |
November 30, 2021 | 99.71% |
October 31, 2021 | 99.71% |
September 30, 2021 | 99.71% |
August 31, 2021 | 99.71% |
July 31, 2021 | 99.71% |
June 30, 2021 | 99.76% |
May 31, 2021 | 99.76% |
April 30, 2021 | 99.78% |
March 31, 2021 | 99.79% |
February 28, 2021 | 99.79% |
January 31, 2021 | 99.79% |
December 31, 2020 | 99.83% |
November 30, 2020 | 99.85% |
October 31, 2020 | 99.87% |
September 30, 2020 | 99.88% |
August 31, 2020 | 99.88% |
July 31, 2020 | 99.88% |
June 30, 2020 | 99.88% |
May 31, 2020 | 99.88% |
April 30, 2020 | 99.88% |
March 31, 2020 | 99.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
99.64%
Minimum
Jan 2023
99.88%
Maximum
May 2019
99.75%
Average
99.71%
Median
Jul 2021
Max Drawdown (5Y) Benchmarks
AIM ImmunoTech Inc | 99.76% |
Perspective Therapeutics Inc | 91.70% |
Protalix BioTherapeutics Inc | 94.35% |
Electromed Inc | 55.84% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -77.82 |
Beta (5Y) | 1.610 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.4% |
Historical Sharpe Ratio (5Y) | -0.5575 |
Historical Sortino (5Y) | -1.183 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.08% |